COVID-19: NAFDAC concludes laboratory analysis of Madagascar drug

Must read

Ndaman Joshua Olayinka
Tech Zealot and Passionate about writing everything concerning it. I support Arsenal.

The National Agency for Food and Drug Administration and Control (NAFDAC) has concluded the laboratory analysis of the Madagascar drug.

The Madagascar drug sample was handed over to NAFDAC by the Madagascar government last week of May 2020. The Government claimed the herbal drug sample could cure COVID-19 symptoms.

The drug sample, which was also shared with the National Institute for Pharmaceutical Research and Development, and the Nigerian Institute of Medical Research, has now spent seven weeks with the agencies.

According to Punch Nigeria, a top official privy to the development said NAFDAC had completed its analysis and the report would be forwarded to the PTF and Minister of Health, Dr Osagie Ehanire any moment from now.

The source said, “NAFDAC’s laboratory people have concluded their own analysis. The agency’s director of laboratories will forward it to the Director-General and the DG will forward it to the Minister of Health who is a member of the Presidential Task Force.

“So, it is a procedural thing. Whether it can cure or not, I cannot say until the report gets to the DG and to the minister.”

Read Also: Russia completes clinical trials of COVID-19 vaccine

The Director-General, NAFDAC, Pro Mojisola Adeyeye, had said that aside from the Madagascar drug, the agency was analysing other local herbal samples which laid claim to COVID-19 cure.

On May 28, at a PTF briefing in Abuja, minister of health confirmed that the Madagascar drug samples had been handed over to NAFDAC, NIPRD and NIMR for analyses.

Meanwhile, NIPRD had said its findings showed that the drug samples could not cure COVID-19, contrary to the claim by the Madagascar authorities.

Source: Punch Nigeria

More articles

Leave A Reply

Please enter your comment!
Please enter your name here

Latest article